Premium
P3‐425: Safety, tolerability and efficacy of lecozotan SR in patients with mild‐to‐moderate Alzheimer's disease used as monotherapy or adjunctively with a cholinesterase inhibitor
Author(s) -
Booth Kevin,
Zhao Yonggang,
Hua Yue,
Wilks Kerri,
Solomon Paul,
Lucas Prisca,
Murray Ermellina,
Raje Sangeeta,
Black Ronald S.
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.2099
Subject(s) - tolerability , placebo , donepezil , medicine , adverse effect , clinical endpoint , population , nausea , cholinesterase , dementia , randomized controlled trial , disease , pathology , alternative medicine , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom